Raydn Back to the front page ◐ StockIONSIonis Pharma45.73+0.73%at the closePrice as of Wednesday, October 21, 2026 at 8:42 PM ETRaydn storiesOct 21, 4:18 PM ETGSK wins FDA approval for Hibsago, a hepatitis B drug licensed from Ionis